Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Aug 9, 2024 · 10-Q · 40 days after period end · 0001516551-24-000070
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$7.90M | -$3.11M | -$3.42M | -$2.02M |
| EPS Diluted | -$0.20 | -$0.80 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 9, 2024 · 40 d after period end
